Matches in Nanopublications for { ?s ?p "[Because the expression of lipocalin-2 (LCN2) was highly enhanced by promoter hypomethylation in inorganic arsenic (iAs)-HUCs cells as well as bladder cancer tissues, we further showed that mutations at the binding sequences for NF-?B and C/EBP-? significantly reduced LCN2 promoter activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- assertion description "[Because the expression of lipocalin-2 (LCN2) was highly enhanced by promoter hypomethylation in inorganic arsenic (iAs)-HUCs cells as well as bladder cancer tissues, we further showed that mutations at the binding sequences for NF-?B and C/EBP-? significantly reduced LCN2 promoter activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Because the expression of lipocalin-2 (LCN2) was highly enhanced by promoter hypomethylation in inorganic arsenic (iAs)-HUCs cells as well as bladder cancer tissues, we further showed that mutations at the binding sequences for NF-?B and C/EBP-? significantly reduced LCN2 promoter activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Because the expression of lipocalin-2 (LCN2) was highly enhanced by promoter hypomethylation in inorganic arsenic (iAs)-HUCs cells as well as bladder cancer tissues, we further showed that mutations at the binding sequences for NF-?B and C/EBP-? significantly reduced LCN2 promoter activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Because the expression of lipocalin-2 (LCN2) was highly enhanced by promoter hypomethylation in inorganic arsenic (iAs)-HUCs cells as well as bladder cancer tissues, we further showed that mutations at the binding sequences for NF-?B and C/EBP-? significantly reduced LCN2 promoter activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Because the expression of lipocalin-2 (LCN2) was highly enhanced by promoter hypomethylation in inorganic arsenic (iAs)-HUCs cells as well as bladder cancer tissues, we further showed that mutations at the binding sequences for NF-?B and C/EBP-? significantly reduced LCN2 promoter activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Because the expression of lipocalin-2 (LCN2) was highly enhanced by promoter hypomethylation in inorganic arsenic (iAs)-HUCs cells as well as bladder cancer tissues, we further showed that mutations at the binding sequences for NF-?B and C/EBP-? significantly reduced LCN2 promoter activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1158212.RADTaJcGJykS__dlyMISPs10_-ym7uthFxrz2eRw7XQs4130_assertion description "[Because the expression of lipocalin-2 (LCN2) was highly enhanced by promoter hypomethylation in inorganic arsenic (iAs)-HUCs cells as well as bladder cancer tissues, we further showed that mutations at the binding sequences for NF-?B and C/EBP-? significantly reduced LCN2 promoter activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158212.RADTaJcGJykS__dlyMISPs10_-ym7uthFxrz2eRw7XQs4130_provenance.
- NP1158210.RArIVWn09bLH5o3Xe8Uq-_wBTl7-luNWU9FK9EgbVTxCI130_assertion description "[Because the expression of lipocalin-2 (LCN2) was highly enhanced by promoter hypomethylation in inorganic arsenic (iAs)-HUCs cells as well as bladder cancer tissues, we further showed that mutations at the binding sequences for NF-?B and C/EBP-? significantly reduced LCN2 promoter activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158210.RArIVWn09bLH5o3Xe8Uq-_wBTl7-luNWU9FK9EgbVTxCI130_provenance.
- NP1158211.RAPyeI4dU8igWF5KER6UUxQ_SHVPSF2sBt5Cs3hW8FOS0130_assertion description "[Because the expression of lipocalin-2 (LCN2) was highly enhanced by promoter hypomethylation in inorganic arsenic (iAs)-HUCs cells as well as bladder cancer tissues, we further showed that mutations at the binding sequences for NF-?B and C/EBP-? significantly reduced LCN2 promoter activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158211.RAPyeI4dU8igWF5KER6UUxQ_SHVPSF2sBt5Cs3hW8FOS0130_provenance.
- NP1158213.RA4S3f08OwDXigIRMe6T2MmIn8fwIgyYPLeb0jn5cOQts130_assertion description "[Because the expression of lipocalin-2 (LCN2) was highly enhanced by promoter hypomethylation in inorganic arsenic (iAs)-HUCs cells as well as bladder cancer tissues, we further showed that mutations at the binding sequences for NF-?B and C/EBP-? significantly reduced LCN2 promoter activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158213.RA4S3f08OwDXigIRMe6T2MmIn8fwIgyYPLeb0jn5cOQts130_provenance.